Fig. 1From: Efficacy and safety of radiotherapy plus anti-PD1 versus transcatheter arterial chemoembolization plus sorafenib for advanced hepatocellular carcinoma: a real-world studyPatient selection flow. HCC Hepatocellular carcinoma; TACE Transcatheter arterial chemoembolization; ICC Intrahepatic cholangiocarcinoma; RT Radiotherapy; PD1 Monoclonal antibody against programmed cell deathBack to article page